Interaction of the Oncofetal Thomsen–Friedenreich Antigen with Galectins in Cancer Progression and Metastasis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interaction of the Oncofetal Thomsen–Friedenreich Antigen with Galectins in Cancer Progression and Metastasis
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-03-31
DOI
10.3389/fonc.2016.00079
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thermodynamic Switch in Binding of Adhesion/Growth Regulatory Human Galectin-3 to Tumor-Associated TF Antigen (CD176) and MUC1 Glycopeptides
- (2015) Maria C. Rodriguez et al. BIOCHEMISTRY
- What controls the expression of the core-1 (Thomsen—Friedenreich) glycotope on tumor cells?
- (2015) U. Karsten et al. BIOCHEMISTRY-MOSCOW
- Galectin-3 Binding Protein and Galectin-1 Interaction in Breast Cancer Cell Aggregation and Metastasis
- (2015) Tzu-Wen Lin et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer
- (2015) Bianca T. Hofmann et al. Molecular Cancer
- Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis
- (2015) Carrie A Duckworth et al. Oncotarget
- The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL
- (2015) Richard Beatson et al. PLoS One
- Structural Basis Underlying the Binding Preference of Human Galectins-1, -3 and -7 for Galβ1-3/4GlcNAc
- (2015) Tung-Ju Hsieh et al. PLoS One
- Development, Characterization, and Immunotherapeutic Use of Peptide Mimics of the Thomsen-Friedenreich Carbohydrate Antigen
- (2015) Jamie Heimburg-Molinaro et al. NEOPLASIA
- Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
- (2014) Nicola Aceto et al. CELL
- Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43
- (2014) Franca Maria Tuccillo et al. Biomed Research International
- A monosaccharide-modified peptide phage library for screening of ligands to carbohydrate-binding proteins
- (2013) Kanako Arai et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The molecular chaperone cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK
- (2013) John Huang et al. MOLECULAR CARCINOGENESIS
- Cell surface protein glycosylation in cancer
- (2013) Maja N. Christiansen et al. PROTEOMICS
- Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancer
- (2013) Jie Chen WORLD JOURNAL OF GASTROENTEROLOGY
- What makes cancer stem cell markers different?
- (2013) Uwe Karsten et al. SpringerPlus
- Molecular Recognition of the Thomsen-Friedenreich Antigen–Threonine Conjugate by Adhesion/Growth Regulatory Galectin-3: Nuclear Magnetic Resonance Studies and Molecular Dynamics Simulations
- (2012) Austin B. Yongye et al. BIOCHEMISTRY
- Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer
- (2012) Ha-Jeong Kim et al. HUMAN PATHOLOGY
- Vertebrate protein glycosylation: diversity, synthesis and function
- (2012) Kelley W. Moremen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Serum Galectin-2, -4, and -8 Are Greatly Increased in Colon and Breast Cancer Patients and Promote Cancer Cell Adhesion to Blood Vascular Endothelium
- (2011) H. Barrow et al. CLINICAL CANCER RESEARCH
- Structural Basis for Distinct Binding Properties of the Human Galectins to Thomsen-Friedenreich Antigen
- (2011) Cheng-Feng Bian et al. PLoS One
- Novel Interaction of MUC4 and Galectin: Potential Pathobiological Implications for Metastasis in Lethal Pancreatic Cancer
- (2010) S. Senapati et al. CLINICAL CANCER RESEARCH
- Structural insights into the recognition mechanism between an antitumor galectin AAL and the Thomsen-Friedenreich antigen
- (2010) Lei Feng et al. FASEB JOURNAL
- Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis
- (2010) Qicheng Zhao et al. Molecular Cancer
- Synthesis and screening of a small glycomimetic library for inhibitory activity on medically relevant galactoside-specific lectins in assays of increasing biorelevance
- (2010) Sabine André et al. NEW JOURNAL OF CHEMISTRY
- Cosmc is an essential chaperone for correct protein O-glycosylation
- (2010) Y. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating Galectin-3 Promotes Metastasis by Modifying MUC1 Localization on Cancer Cell Surface
- (2009) Q. Zhao et al. CANCER RESEARCH
- Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc
- (2008) T. Ju et al. CANCER RESEARCH
- Expression of CD175 (Tn), CD175s (sialosyl-Tn) and CD176 (Thomsen-Friedenreich antigen) on malignant human hematopoietic cells
- (2008) Yi Cao et al. INTERNATIONAL JOURNAL OF CANCER
- Galectin-1, -2, and -3 Exhibit Differential Recognition of Sialylated Glycans and Blood Group Antigens
- (2008) Sean R. Stowell et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Arginine Binding Motifs: Design and Synthesis of Galactose-Derived Arginine Tweezers as Galectin-3 Inhibitors
- (2008) Christopher T. Öberg et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now